REYON Pharmaceutical Market Cap

REYON Pharmaceutical has a market cap or net worth of 192.58 billion as of March 13, 2026. Its market cap has decreased by -19.79% in one year.

Market Cap

192.58B

Enterprise Value

398.28B

Revenue

149.34B

Ranking

n/a

PE Ratio

n/a

Stock Price

10,500.00

Market Cap Chart

Since June 10, 2010, REYON Pharmaceutical's market cap has increased from 164.55B to 192.58B, an increase of 17.03%. That is a compound annual growth rate of 1.00%.

Market Cap History

Date	Market Cap	% Change
Mar 12, 2026	190.75B	-3.53%
Dec 30, 2025	197.72B	-16.04%
Dec 30, 2024	235.50B	-22.37%
Dec 28, 2023	303.36B	-21.07%
Dec 29, 2022	384.35B	-39.10%
Dec 30, 2021	631.11B	61.64%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daewon Pharmaceutical	223.34B
Samjin Pharmaceuticals	220.39B
Jeil Pharmaceutical Co.,Ltd	213.04B
HLB Pharmaceutical	209.65B
Samil Pharmaceutical Co.,Ltd	207.84B
JW Lifescience	200.37B
AptaBio Therapeutics	198.90B
Daihan Pharmaceutical	172.58B

Market Cap Rankings